Tom Jefferson1, Elisabeth A Spencer2, Jon Brassey3, Carl Heneghan2. 1. Department of Continuing Education, University of Oxford, Oxford, United Kingdom. 2. Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom. 3. Trip Database Ltd, Bristol, United Kingdom.
Abstract
BACKGROUND: We aimed to review the evidence from studies relating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) culture with the results of reverse-transcription polymerase chain reaction (RT-PCR) and other variables that may influence the interpretation of the test, such as time from symptom onset. METHODS: We searched LitCovid, medRxiv, Google Scholar, and the World Health Organization coronavirus disease 2019 (COVID-19) database for COVID-19 up to 10 September 2020. We included studies attempting to culture or observe SARS-CoV-2 in specimens with RT-PCR positivity. Studies were dual-extracted and the data summarized narratively by specimen type. Where necessary, we contacted corresponding authors of included papers for additional information. We assessed quality using a modified Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS 2) risk-of-bias tool. RESULTS: We included 29 studies reporting attempts at culturing, or observing tissue infection by, SARS-CoV-2 in sputum, nasopharyngeal or oropharyngeal, urine, stool, blood, and environmental specimens. The quality of the studies was moderate with lack of standardized reporting. The data suggest a relationship between the time from onset of symptom to the timing of the specimen test, cycle threshold (Ct), and symptom severity. Twelve studies reported that Ct values were significantly lower and log copies higher in specimens producing live virus culture. Two studies reported that the odds of live virus culture were reduced by approximately 33% for every 1-unit increase in Ct. Six of 8 studies reported detectable RNA for >14 days, but infectious potential declined after day 8 even among cases with ongoing high viral loads. Four studies reported viral culture from stool specimens. CONCLUSIONS: Complete live viruses are necessary for transmission, not the fragments identified by PCR. Prospective routine testing of reference and culture specimens and their relationship to symptoms, signs, and patient co-factors should be used to define the reliability of PCR for assessing infectious potential. Those with high Ct are unlikely to have infectious potential.
BACKGROUND: We aimed to review the evidence from studies relating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) culture with the results of reverse-transcription polymerase chain reaction (RT-PCR) and other variables that may influence the interpretation of the test, such as time from symptom onset. METHODS: We searched LitCovid, medRxiv, Google Scholar, and the World Health Organization coronavirus disease 2019 (COVID-19) database for COVID-19 up to 10 September 2020. We included studies attempting to culture or observe SARS-CoV-2 in specimens with RT-PCR positivity. Studies were dual-extracted and the data summarized narratively by specimen type. Where necessary, we contacted corresponding authors of included papers for additional information. We assessed quality using a modified Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS 2) risk-of-bias tool. RESULTS: We included 29 studies reporting attempts at culturing, or observing tissue infection by, SARS-CoV-2 in sputum, nasopharyngeal or oropharyngeal, urine, stool, blood, and environmental specimens. The quality of the studies was moderate with lack of standardized reporting. The data suggest a relationship between the time from onset of symptom to the timing of the specimen test, cycle threshold (Ct), and symptom severity. Twelve studies reported that Ct values were significantly lower and log copies higher in specimens producing live virus culture. Two studies reported that the odds of live virus culture were reduced by approximately 33% for every 1-unit increase in Ct. Six of 8 studies reported detectable RNA for >14 days, but infectious potential declined after day 8 even among cases with ongoing high viral loads. Four studies reported viral culture from stool specimens. CONCLUSIONS: Complete live viruses are necessary for transmission, not the fragments identified by PCR. Prospective routine testing of reference and culture specimens and their relationship to symptoms, signs, and patient co-factors should be used to define the reliability of PCR for assessing infectious potential. Those with high Ct are unlikely to have infectious potential.
Authors: Jacqueline Steinlin-Schopfer; Maria Teresa Barbani; Richard Kamgang; Martina Zwahlen; Franziska Suter-Riniker; Ronald Dijkman Journal: J Clin Virol Plus Date: 2021-05-09
Authors: Di Tian; Zhen Lin; Ellie M Kriner; Dalton J Esneault; Jonathan Tran; Julia C DeVoto; Naima Okami; Rachel M Greenberg; Sarah Yanofsky; Swarnamala Ratnayaka; Nicholas Tran; Maeghan Livaccari; Marla L Lampp; Noel Wang; Scott Tim; Patrick Norton; John Scott; Tony Y Hu; Robert Garry; Lee Hamm; Patrice Delafontaine; Xiao-Ming Yin Journal: J Mol Diagn Date: 2021-06-05 Impact factor: 5.568
Authors: Rodrigo M Young; Camila J Solis; Andres Barriga-Fehrman; Carlos Abogabir; Alvaro R Thadani; Mariana Labarca; Eva Bustamante; Cecilia V Tapia; Antonia G Sarda; Francisca Sepulveda; Nadia Pozas; Leslie C Cerpa; María A Lavanderos; Nelson M Varela; Alvaro Santibañez; Ana M Sandino; Felipe Reyes-Lopez; Garth Dixon; Luis A Quiñones Journal: Elife Date: 2021-06-22 Impact factor: 8.140
Authors: Nicole Stoesser; Philippa C Matthews; David W Eyre; A Sarah Walker; Emma Pritchard; Thomas House; Julie V Robotham; Paul J Birrell; Iain Bell; John I Bell; John N Newton; Jeremy Farrar; Ian Diamond; Ruth Studley; Jodie Hay; Karina-Doris Vihta; Timothy Ea Peto; Koen B Pouwels Journal: Elife Date: 2021-07-12 Impact factor: 8.140
Authors: Kanan T Desai; Karla Alfaro; Laura Mendoza; Matthew Faron; Brian Mesich; Mauricio Maza; Rhina Dominguez; Adriana Valenzuela; Chyntia Díaz Acosta; Magaly Martínez; Juan C Felix; Rachel Masch; Sofia Gabrilovich; Michael Plump; Akiva P Novetsky; Mark H Einstein; Nataki C Douglas; Miriam Cremer; Nicolas Wentzensen Journal: medRxiv Date: 2021-07-06